000 01201 a2200325 4500
005 20250514002418.0
264 0 _c20010906
008 200109s 0 0 eng d
022 _a0168-1656
024 7 _a10.1016/s0168-1656(01)00238-3
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aFonjallaz , P
245 0 0 _aRecombinant hCG (OVIDREL) and recombinant interferon-(beta)1a (REBIF). (No. 13 in a series of articles to promote a better understanding of the use of genetic engineering).
_h[electronic resource]
260 _bJournal of biotechnology
_cMay 2001
300 _a279-81 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAnimals
650 0 4 _aCHO Cells
650 0 4 _aChorionic Gonadotropin
_xgenetics
650 0 4 _aClinical Trials as Topic
650 0 4 _aCricetinae
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aInfertility, Female
_xdrug therapy
650 0 4 _aProtein Engineering
_xmethods
650 0 4 _aRecombinant Proteins
_xgenetics
700 1 _aLoumaye, E
773 0 _tJournal of biotechnology
_gvol. 87
_gno. 3
_gp. 279-81
856 4 0 _uhttps://doi.org/10.1016/s0168-1656(01)00238-3
_zAvailable from publisher's website
999 _c11341578
_d11341578